Mark V. Koning

Rijnstate Hospital

Papers

2

Total Citations

64

H-Index

2

About

Mark V. Koning is an anesthesiologist and clinical researcher whose work centers on optimizing perioperative pain management and recovery in major urologic surgeries. His primary research areas include regional anesthesia techniques—particularly neuraxial analgesia—and their impact on postoperative quality of recovery, opioid consumption, and complication rates. Koning’s most influential contribution is a landmark randomized controlled trial (2019, 61 citations) demonstrating that intrathecal bupivacaine/morphine significantly improves early recovery quality after robot-assisted radical prostatectomy, establishing a new standard for multimodal analgesia in this procedure. He has also advanced the field through retrospective analyses comparing intrathecal morphine to epidural analgesia in robot-assisted radical cystectomy, providing critical evidence for safer, more effective pain control that facilitates early mobilization and enteral nutrition. His work directly addresses the challenge of balancing potent analgesia with minimal side effects in minimally invasive surgery. By rigorously evaluating alternative regional techniques, Koning has helped shift clinical practice toward simpler, opioid-sparing approaches that enhance patient recovery. His research is essential reading for anesthesiologists and surgeons seeking evidence-based strategies to improve surgical outcomes and patient experience.

Research Focus

Key Achievements

2
H-Index
2
Papers
64
Total Citations
32
Avg Citations/Paper
🏆 Most Cited Paper
The effect of intrathecal bupivacaine/morphine on quality of recovery in robot‐assisted radical prostatectomy: a randomised controlled trial
61 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Rijnstate Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago